On September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac's base salary is $250,000 and he will be eligible to participate in the company's benefits plan as of October 1, 2022.

Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac's work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.